- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04663529
Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers
May 31, 2022 updated by: Peking University Third Hospital
This study aims to analyze the changes of corneal nerve morphology and function in contact lens-related dry eye(CLADE) patients and further discuss the role of corneal nerve in the genesis and development of CLADE.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
33 daily disposable soft contact lens wearers with dry eye disease(DED), 33 DED without contact lens wear and 33 normal control subjects will be involved in study.
One experienced ophthalmologist will evaluate the DED symptoms and signs, which include ocular surface disease index(OSDI), tear film breakup time(TBUT), Schirmer Ⅰ test, corneal fluorescein staining, lissamine green staining and meibomian gland dropout rate.
After evaluating, corneal sensitivity are measured using a Cochet-Bonnet aesthesiometer.
Corneal nerve morphology will be assessed in the right eye using in vivo confocal microscopy(IVCM).
Fifteen to twenty minutes after IVCM, 20μL of basal tears will be collected from the inferior meniscus of each participant to test tear neuropeptides.
Then investigators analyse the correlation of corneal nerve changes and DED symptoms and signs.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Peking University Third Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
DED patients from Peking University Third Hospital
Description
Inclusion Criteria:
- Age 18years to 40 years;
- Male or female DED patients based on Chinese Dry Eye Diagnosis Standard (2020) with or without contact lens wear;
- Provision of written informed consent.
Exclusion Criteria:
- Presence of any of the following conditions: active ocular infection, ocular inflammation, active ocular allergy, ocular surgical history, laser treatment in the last 3 months, Meibomian function (MGD) over grade 2 (the grade is according to the report of the International Workshop on MGD in 2011), severe blepharitis or obvious inflammation of the eyelid margin, which in the judgment of the investigator may interfere with the interpretation of the study results
- Pregnant and lactating women, or those planning a pregnancy over the course of the study
- Uncontrolled systemic disease
- Suffer from diseases that may affect corneal nerves, such as keratoconus, trigeminal neuralgia, allergic conjunctivitis, etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CLADE
contact lens wearers with DED
|
daily disposable soft contact lens
|
|
non-CLADE
DED without contact lens wear
|
|
|
NC
normal control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sub-basal corneal nerve density
Time Frame: baseline
|
Sub-basal corneal nerve plexus image will be acquired using a laser scanning confocal microscope.
Sub-basal nerve fiber density will be calculated from a manual trace of the length of all nerve fibers in each 1 mm2 image.
|
baseline
|
|
sub-basal corneal nerve tortuosity
Time Frame: baseline
|
Sub-basal corneal nerve plexus image will be acquired using a laser scanning confocal microscope.
Sub-basal nerve tortuosity will be assessed using a grading scale separately by two experienced ophthamologist.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ocular surface disease index(OSDI)
Time Frame: baseline
|
OSDI is one of the most frequently used questionnaires for evaluation of DED.
This includes 12 questions which measure the frequency of symptoms over the recent week, and the scores range from 0 to 100.
|
baseline
|
|
Tear break-up time (TBUT)
Time Frame: baseline
|
TBUT is the time from normal blinking to the first appearance of a break in the tear film.
|
baseline
|
|
Schirmer Ⅰ test (SⅠt)
Time Frame: baseline
|
The Schirmer I test is performed using sterile strips without anesthesia.
The strips are placed in the lateral part of the inferior fornix of the eye for 5min and the extent of tear flow down was measured in millimeters.
|
baseline
|
|
Corneal fluorescein staining
Time Frame: baseline
|
The degree of fluorescein staining of the cornea was evaluated using the National Eye Institute (NEI) scale of five corneal regions (central, superior, temporal, nasal, and inferior).
|
baseline
|
|
Lissamine green staning
Time Frame: baseline
|
To grade the temporal zone, the subject looks nasally; to grade the nasal zone the subject looks temporally.
The upper and lower conjunctiva can also be graded.
|
baseline
|
|
meibomian gland droupout rate
Time Frame: baseline
|
meibomian gland evaluation
|
baseline
|
|
corneal sensitivity
Time Frame: baseline
|
Corneal sensitivity will be measured in the right eye only using the Cochet-Bonnet aesthesiometer and the ascending method of limits to determine the threshold of stimulus detection.
|
baseline
|
|
the concentration of substance P
Time Frame: baseline
|
20μL of basal tears will be collected from the inferior meniscus of each subject to test substance P. Substance P levels will be quantified by competitive enzyme-linked immunosorbent assays.
|
baseline
|
|
the concentration of CGRP
Time Frame: baseline
|
CGRP levels will be quantified by competitive enzyme-linked immunosorbent assays.
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Actual)
May 1, 2021
Study Completion (Actual)
October 1, 2021
Study Registration Dates
First Submitted
September 16, 2020
First Submitted That Met QC Criteria
December 6, 2020
First Posted (Actual)
December 11, 2020
Study Record Updates
Last Update Posted (Actual)
June 1, 2022
Last Update Submitted That Met QC Criteria
May 31, 2022
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLADE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
BioTissue Holdings, IncCompletedDry Eye | Dry Eye Disease (DED) | Dry Eye Disease With Severe KeratitisUnited States
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
Clinical Trials on contact lens
-
CIBA VISIONCompleted
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
University of RochesterCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompleted